April 19, 2018 6:59 AM ET


Company Overview of Acceleron Pharma Inc.

Key Executives for Acceleron Pharma Inc.

NameBoard RelationshipsTitleAge
Habib J. Dable 13 RelationshipsCEO, President & Director48
Thomas P. Maniatis 17 RelationshipsCo-Founder, Member of Scientific Advisory Board & Director74
Mark Ptashne Ph.D.30 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Kevin F. McLaughlin 11 RelationshipsCFO, Senior VP, Treasurer & Principal Accounting Officer61
Sujay Kango No RelationshipsChief Commercial Officer53
View More Key Executives

Acceleron Pharma Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Francois Nader 44 RelationshipsAcceleron Pharma Inc.60
Habib J. Dable 13 RelationshipsAcceleron Pharma Inc.48
Thomas P. Maniatis 17 RelationshipsAcceleron Pharma Inc.74
Mark Ptashne Ph.D. 30 RelationshipsAcceleron Pharma Inc.--
Jean M. George 70 RelationshipsLightstone Ventures59
View All Board Members

Acceleron Pharma Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Joseph S. Zakrzewski79 Relationships4 Executives
Compensation Committee Terrence C. Kearney31 Relationships4 Executives
Nominating Committee Jean M. George70 Relationships4 Executives
Corporate Governance Committee Jean M. George70 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$395.8K
Compensation as of Fiscal Year 2016
Acceleron Pharma Inc. CEO Compensation
Industry Average


Phylogica Announces Management Changes
April 10, 2018 11:43 PM ET
Rosetta Genomics Ltd. Announces Resignation of Ken Berlin as President and CEO, Effective April 18, 2018
April 10, 2018 8:04 PM ET
ReNeuron Group plc Announces Executive Changes
April 10, 2018 12:00 PM ET
ProQR Therapeutics N.V. Appoints Dr. Peter A. Beal to Scientific Advisory Board
April 10, 2018 11:00 AM ET
Collagen Solutions plc Appoints Louis T. Ruggiero as Chief Business Officer effective as of 16 April 2018
April 10, 2018 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acceleron Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.